Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia.

To assess the benefits and harm of administering anticonvulsants to infants of 37 weeks gestation or more following perinatal asphyxia with the primary aims of prevention of death or subsequent severe neurodevelopmental disability and/or the prevention of seizures.